DDN, the global leader in AI and data intelligence solutions, is unveiling xFusionAI, a revolutionary AI infrastructure that merges best-in-class training and inference performance into a single, ...
AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback